Over the past decade, lung cancer treatment has undergone a major paradigm shift. A
greater understanding of lung cancer biology has led to the development of many effective …

Exosomes are cell-derived vesicles containing heterogeneous active biomolecules such as
proteins, lipids, mRNAs, receptors, immune regulatory molecules, and nucleic acids. They …

In Europe, lung cancer ranks third among the most common cancers, remaining the biggest
killer. Since the publication of the first European Society of Radiology and European …

Simple Summary Cancer is one of the most debated problems all over the world. Cancer
stem cells are considered responsible of tumor initiation, metastasis, drug resistance, and …

Early, express, and reliable detection of cancer can provide a favorable prognosis and
decrease mortality. Tumor biomarkers have been proven to be closely related to tumor …

With the advances of liquid biopsy technology, there is increasing evidence that body fluid
such as blood, urine, and saliva could harbor the potential biomarkers associated with tumor …

Despite the availability of various diagnostic procedures, a tissue biopsy is still
indispensable for the routine diagnosis of lung cancer. However, inaccurate diagnoses can …

Long noncoding RNA (lncRNA) LINC00857 has been reported to be upregulated in lung
cancer and related to poor patient survival. It can regulate cell proliferation and tumor growth …

The five-year survival rate of lung cancer patients is very low, mainly because most newly
diagnosed patients present with locally advanced or metastatic disease. Therefore, early …

Non–small cell lung cancer (NSCLC) is the most commonly diagnosed cancer and the
leading cause of cancer death worldwide. More than half of patients with NSCLC die after …